Abstract
Effects of neomycin were studied on serum cholesterol and fecal steroids in hypercholesterolemic patients during a short treatment period (4 wk) and a long treatment period (16 mo), using small (1.5 g/d) and large (up to 6 g/d) doses alone and in combination with cholestyramine. In the short-term low-dose study the decrease in serum cholesterol by 21% was associated with a proportionate increase in fecal cholesterol elimination as neutral sterols through impaired cholesterol absorption. Serum cholesterol remained low and fecal steroid excretion remained elevated in the long-term neomycin study. Increasing the dosage from 1.5 to 6 g/d at the end of the 16-mo period brought about a further slight decrease in serum cholesterol and a small further increase in fecal neutral and acidic steroids. The increases in fecal bile acids and fat but not in neutral sterols were positively correlated with the increases in the neomycin dosage. Thus, large neomycin doses can also cause bile acid malabsorption. In another series of patients, a decrease (25%) in serum cholesterol by cholestyramine was associated with a proportional increase in the fecal elimination of cholesterol (2.5-fold) as bile acids. The inclusion of neomycin in cholestyramine therapy further increased fecal steroid output (solely as neutral sterols) by only about one-fifth of that due to cholestyramine, but further decreased serum cholesterol almost to the same extent (-17%) as cholestyramine alone. The overall decrease was 38%, no side effects occurred, and the patients found combination therapy convenient. Neomycin decreased serum cholesterol in different studies by 10±2, 17±4, and 12±4% per 100 mg/d of the increment in fecal steroids, the respective decrease for cholestyramine being only 2.2±0.5%. Thus, neomycin effectively reduced serum cholesterol by a relatively small increase in cholesterol elimination (via cholesterol malabsorption) compared with cholestyramine-induced bile acid malabsorption.
Full text
PDF








Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BOLIN D. W., KING R. P., KLOSTERMAN E. W. A simplified method for the determination of chromic oxide (Cr2 O3) when used as an index substance. Science. 1952 Dec 5;116(3023):634–635. doi: 10.1126/science.116.3023.634. [DOI] [PubMed] [Google Scholar]
- BORGSTROEM B., LUNDH G., HOFMANN A. THE SITE OF ABSORPTION OF CONJUGATED BILE SALTS IN MAN. Gastroenterology. 1963 Aug;45:229–238. [PubMed] [Google Scholar]
- Bennion L. J., Grundy S. M. Effects of obesity and caloric intake on biliary lipid metabolism in man. J Clin Invest. 1975 Oct;56(4):996–1011. doi: 10.1172/JCI108180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Berk D. P., Chalmers T. Deafness complicating antibiotic therapy of hepatic encephalopathy. Ann Intern Med. 1970 Sep;73(3):393–396. doi: 10.7326/0003-4819-73-3-393. [DOI] [PubMed] [Google Scholar]
- Cayen M. N. Agents affecting lipid metabolism. 38. Effect of neomycin on cholesterol biosynthesis and bile acid precipitation. Am J Clin Nutr. 1970 Sep;23(9):1234–1240. doi: 10.1093/ajcn/23.9.1234. [DOI] [PubMed] [Google Scholar]
- DESOMER P., VANDERHAEGHE H., EYSSEN H. INFLUENCE OF BASIC ANTIBIOTICS ON SERUM- AND LIVER-CHOLESTEROL CONCENTRATIONS IN CHICKS. Nature. 1964 Dec 26;204:1306–1306. doi: 10.1038/2041306a0. [DOI] [PubMed] [Google Scholar]
- Eyssen H., Evrard E., Vanderhaeghe H. Cholesterol-lowering effects of N-methylated neomycin and basic antibiotics. J Lab Clin Med. 1966 Nov;68(5):753–768. [PubMed] [Google Scholar]
- GOLDSMITH G. A., HAMILTON J. G., MILLER O. N. Lowering of serum lipid concentrations: mechanisms used by unsaturated fats, nicotinic acid, and neomycin: excretion of sterols and bile acids. Arch Intern Med. 1960;105:512–517. [PubMed] [Google Scholar]
- GRUNDY S. M., AHRENS E. H., Jr, MIETTINEN T. A. QUANTITATIVE ISOLATION AND GAS--LIQUID CHROMATOGRAPHIC ANALYSIS OF TOTAL FECAL BILE ACIDS. J Lipid Res. 1965 Jul;6:397–410. [PubMed] [Google Scholar]
- Grundy S. M., Ahrens E. H., Jr, Salen G. Dietary beta-sitosterol as an internal standard to correct for cholesterol losses in sterol balance studies. J Lipid Res. 1968 May;9(3):374–387. [PubMed] [Google Scholar]
- Grundy S. M., Ahrens E. H., Jr, Salen G. Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism. J Lab Clin Med. 1971 Jul;78(1):94–121. [PubMed] [Google Scholar]
- Grundy S. M. Treatment of hypercholesterolemia by interference with bile acid metabolism. Arch Intern Med. 1972 Oct;130(4):638–648. [PubMed] [Google Scholar]
- Hardison W. G., Rosenberg I. H. The effect of neomycin on bile salt metabolism and fat digestion in man. J Lab Clin Med. 1969 Oct;74(4):564–573. [PubMed] [Google Scholar]
- JACOBSON E. D., CHODOS R. B., FALOON W. W. An experimental malabsorption syndrome induced by neomycin. Am J Med. 1960 Apr;28:524–533. doi: 10.1016/0002-9343(60)90146-7. [DOI] [PubMed] [Google Scholar]
- JACOBSON E. D., PRIOR J. T., FALOON W. W. Malabsorptive syndrome induced by neomyclin: morphologic alterations in the jejunal mucosa. J Lab Clin Med. 1960 Aug;56:245–250. [PubMed] [Google Scholar]
- MIETTINEN T. A., AHRENS E. H., Jr, GRUNDY S. M. QUANTITATIVE ISOLATION AND GAS--LIQUID CHROMATOGRAPHIC ANALYSIS OF TOTAL DIETARY AND FECAL NEUTRAL STEROIDS. J Lipid Res. 1965 Jul;6:411–424. [PubMed] [Google Scholar]
- Miettinen T. A. New insights into cholesterol dynamics. Arch Surg. 1978 Jan;113(1):45–49. doi: 10.1001/archsurg.1978.01370130047007. [DOI] [PubMed] [Google Scholar]
- Morgan R. G., Borgström B. The mechanism of fat absorption in the bile fistula rat. Q J Exp Physiol Cogn Med Sci. 1969 Apr;54(2):228–243. doi: 10.1113/expphysiol.1969.sp002021. [DOI] [PubMed] [Google Scholar]
- Nervi F. O., Dietschy J. M. The mechanisms of and the interrelationship between bile acid and chylomicron-mediated regulation of hepatic cholesterol synthesis in the liver of the rat. J Clin Invest. 1978 Apr;61(4):895–909. doi: 10.1172/JCI109015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- POWELL R. C., NUNES W. T., HARDING R. S., VACCA J. B. The influence of nonabsorbable antibiotics on serum lipids and the excretion of neutral sterols and bile acids. Am J Clin Nutr. 1962 Aug;11:156–168. doi: 10.1093/ajcn/11.2.156. [DOI] [PubMed] [Google Scholar]
- Rubulis A., Rubert M., Faloon W. W. Cholesterol lowering, fecal bile acid, and sterol changes during neomycin and colchicine. Am J Clin Nutr. 1970 Sep;23(9):1251–1259. doi: 10.1093/ajcn/23.9.1251. [DOI] [PubMed] [Google Scholar]
- SAMUEL P., STEINER A. Effect of neomycin on serum cholesterol level of man. Proc Soc Exp Biol Med. 1959 Jan;100(1):193–195. doi: 10.3181/00379727-100-24569. [DOI] [PubMed] [Google Scholar]
- SIPERSTEIN M. D., CHAIKOFF I. L., REINHARDT W. O. C14-Cholesterol. V. Obligatory function of bile in intestinal absorption of cholesterol. J Biol Chem. 1952 Sep;198(1):111–114. [PubMed] [Google Scholar]
- Samuel P., Holtzman C. H., Meilman E., Perl W. Effect of neomycin on exchangeable pools of cholesterol in the steady state. J Clin Invest. 1968 Aug;47(8):1806–1818. doi: 10.1172/JCI105870. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Samuel P., Holtzman C. M., Goldstein J. Long-term reduction of serum cholesterol levels of patients with atherosclerosis by small doses of neomycin. Circulation. 1967 May;35(5):938–945. doi: 10.1161/01.cir.35.5.938. [DOI] [PubMed] [Google Scholar]
- Schwob D., Rubulis A., Lim E. C., Sherman C. D., Faloon W. W. Effects of neomycin in obese patients with jejunoileostomy. Am J Clin Nutr. 1972 Oct;25(10):987–991. doi: 10.1093/ajcn/25.10.987. [DOI] [PubMed] [Google Scholar]
- Sedaghat A., Samuel P., Crouse J. R., Ahrens E. H., Jr Effects of neomycin on absorption, synthesis, and/or flux of cholesterol in man. J Clin Invest. 1975 Jan;55(1):12–21. doi: 10.1172/JCI107902. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thompson G. R., Barrowman J., Gutierrez L., Dowling R. H. Action of neomycin on the intraluminal phase of lipid absorption. J Clin Invest. 1971 Feb;50(2):319–323. doi: 10.1172/JCI106497. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thompson G. R., MacMahon M., Claes P. Precipitation by neomycin compounds of fatty acid and cholesterol from mixed micellar solutions. Eur J Clin Invest. 1970 Mar;1(1):40–47. doi: 10.1111/j.1365-2362.1970.tb00595.x. [DOI] [PubMed] [Google Scholar]
- Valtonen M. V., Suomalainen R. J., Ylikahri R. H., Valtonen V. V. Selection of multiresistant coliforms by long-term treatment of hypercholesterolaemia with neomycin. Br Med J. 1977 Mar 12;1(6062):683–684. doi: 10.1136/bmj.1.6062.683. [DOI] [PMC free article] [PubMed] [Google Scholar]